Symphony Health Solutions builds a 5-million-patient, longitudinal cardiovascular registry
Collaboration with American College of Cardiology could result in new health-outcomes results
A new analytics platform combines two existing ones: the ACC National Cardiovascular Data Registry, mainly clinical information from anonymized patient records, and the Integrated Dataverse of Horsham, PA-based Symphony Health Solutions (SHS), a longitudinal database that includes prescription data and medical and hospital claims. Together, the database covers approximately five million patients over as long as six years, in a therapy area which remains the largest cause of death in the United States.
“This analytic platform is ground-breaking in the level of data it will provide,” said John S. Rumsfeld, M.D., Ph.D., FACC, Chief Science Officer of the American College of Cardiology National Cardiovascular Data Registries, in a statement. "This creates a synergy that can yield critical insights on improving cardiovascular care and patient outcomes.” Adds Dr. Gregory Hess, MD, MBA, and Chief Medical Officer for Symphony Health Solutions noted, “The detailed cardiology data from the ACC registries collected by practicing physicians over many years allows for a greater range of insights and a more accurate understanding of patient diagnoses, treatments and outcomes than previously afforded by claims data alone.”
The organizations expect to market the data to life sciences organizations, healthcare providers and governments.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
